There has been a LOT of anxious chatter on the board

New Post Public Reply Private Reply Replies (1) Message Board
KolbeB
913
There has been a LOT of anxious chatter on the board lately. I don't mean to be critical at all. It's easy to get drawn into firing off stuff reflexively. I do it, too. For me, I think I need to take a break from it. Relax. I have only moderately proven input.....

I talked with someone close to the situation today. As many have surmised, our "competitor" has lots of money and very effective lobbying, as well as inside influential peer relationships. They are actively using these levers. Why donate over a million doses?.. You flood the market with good news and give the product away, so the "first mover" owns it! Who will the doc's prescribe... the drug they know is free, the one they are familiar with. It's really just great marketing and salesmanship. Proven strategy, too. (Amazon, Netflix, etc)

Yes, IMO, these facts, combined with a natural and urgent need for the administration to instill HOPE and CONFIDENCE in reopening the country ASAP, have created a welcome opportunity to present a virologic med, a path forward. Now we can confidently get the economy restarted. POTUS needs this NOW, not 8 weeks from now. No criticism here. Just MO. It's fine. Some may be helped. We'll move forward....

Meantime, CytoDyn will quietly continue to wrap up two critical trials, publish real data, and simply buoy the country's success celebrated today. In actuality, CytoDyn will come in and rescue this sloppy attempt at saving the world from pandemic. And a year from now, the other solution will fade like burnt out neon. Too many side effects, and too much hassle and cost to administer it. Who wants day after day of IV infusion in a hospital vs. popping one subcu dose a week 2-3X, for pete's sake! IMO of course.

It's like the bridegroom heading to his wedding, the date and time locked in, the guests assembled and waiting, and he realizes his tux is missing its zipper. He staples it with a Swingline, hoping to avoid too much tension, and voila.... the wedding is a success. Meantime, his beautiful new $2,000 tux is being delivered to the reception to carry him into a 75-year happy marriage. No one knows the better.....except the tailor. IMO

Goodnight all!
(that was an awful analogy..... sorry)

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

D-Wave Investors Must Decide by Dec 15 Class Suit

Updated Category News Views 177

Facing the Class Action Deadline There's nothing like a looming deadline to stir the pot, and that's exactly what's happening with D-Wave Quantum Inc. (NASDAQ: QBTS) as it faces the heat of a class action lawsuit. Investors who got caught in the slide between February 26, 2026, and August 25, 2026, need to sharpen their pencils and mark December 15, 2026, on their...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 416

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Sinclair Faces Labor Lawsuit for Break-time Violations

Updated Category News Views 244

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Continue Reading
BAIC FOTON Eyes African Market with Strategic Moves

Updated Category News Views 149

Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...

Continue Reading
Tennessee's Bold Lung Cancer Trial Signals Innovation

Updated Category News Views 268

The Heartbeat of Innovation in Cancer Therapy Who would've thought Tennessee would be at the forefront of a global push against lung cancer? Sure, there's Nashville's music scene, but it's the researchers at Tennessee Oncology who are grooving to a different beat—one that might just set the rhythm for advanced cancer therapies worldwide. Yeah, it's a trial, but not just...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 245

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 267

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading
Air Sealing First: Boosting Home Comfort & Efficiency

Updated Category News Views 191

Everyone wants a cozy, energy-efficient home, right? Well, the first step to achieving that might just surprise you. Forget about shoving more insulation into the walls for a second; air sealing should be your starting line. That's the drum Insulation Expert Mike Mancuso is beating, and he's got a point worth considering before you touch another insulation panel. Cracking...

Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 233

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 260

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading

Top 5 Most Recently Viewed Articles

Legal Rights for Paragon 28, Inc. Shareholders: Essential Info

Updated Category News Views 85

Legal Rights for Shareholders of Paragon 28, Inc. Attention shareholders of Paragon 28, Inc. (NYSE: FNA): As developments unfold regarding potential legal action related to financial misconduct, it is crucial for you to understand your rights and options. If you purchased shares of FNA during the specified class period, there are steps you can take to ensure that your...

Continue Reading
Embecta Set for Upcoming Fiscal Quarter Conference Call

Updated Category News Views 305

Embecta Corp. Financial Results Conference Call Embecta Corp. (“embecta”) (Nasdaq: EMBC), a prominent global player in diabetes care, is gearing up to present its financial performance for the fiscal second quarter of 2025. This pivotal event will offer stakeholders a comprehensive look at the company's recent achievements and ongoing operational updates. Conference...

Continue Reading
Investors Alert: HealthEquity, Inc. under Investigation Now!

Updated Category News Views 153

Investigation of HealthEquity, Inc. Pomerantz LLP is currently investigating claims on behalf of investors from HealthEquity, Inc. (NASDAQ: HQY). Investors who believe they may have been impacted are encouraged to reach out for further information. This investigation focuses on whether HealthEquity and certain officers or directors have been involved in securities fraud...

Continue Reading
Enhancing Access to Mental Health and Dermatology Services

Updated Category News Views 259

Health-E Commerce Teams Up with Sesame for Better Care The new collaboration significantly shortens waiting periods for those seeking mental health and dermatology consultations, delivering substantial savings for millions enrolled in tax-advantaged FSAs and HSAs. Accessible Mental Health and Dermatology Solutions Health-E Commerce, the parent organization behind FSA...

Continue Reading
Massive Gains Expected for Hyperliquid Amid Altcoin Buzz

Updated Category News Views 281

Hyperliquid's Promising Future in the Crypto Market As the cryptocurrency landscape continues to evolve, analysts are closely observing the potential of various altcoins. Recently, a well-known crypto analyst, Sherpa, has highlighted the altcoin Hyperliquid, predicting an exciting journey ahead for its utility token, HYPE. Analyst’s Predictions for Hyperliquid Expected...

Continue Reading